Contraindicated. Coadministration of doravirine with a robust CYP3A inducer may perhaps minimize doravirine plasma concentrations and/or effects. Potential for lack of virologic reaction and possible resistance to doravirine.pentobarbital will lessen the extent or result of estrogens esterified by influencing hepatic/intestinal enzyme CYP3A4 metabo